Cite

HARVARD Citation

    Kawakami, Y. et al. (2016). Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis C: pilot study. Journal of viral hepatitis. 23 (11), pp. 850-856. [Online]. 
  
Back to record